AlertEdge.io
Single-Ticker Trade Brief
HCA — HCA Healthcare Report Date: 2026-10-14 20:38 UTC  |  Sector: Health Care  |  Rating:
RISK DISCLAIMER: This is an automated breakout signal. Always validate before entering a position.
▲ Breakout Signal — Volume Confirmed

HCA closed above the $469.71 breakout level on 1.67x average volume. ATR-based levels set automatically. Next resistance target: $484.91.

Ticker
HCA
Entry Price
$470.46
Breakout Level
$469.71
Stop Loss
$462.48
TP1 Target
$484.91
TP2 Target
$494.54
Risk / Reward
1 : 1.81
1.67x avg volume
View HCA Chart on TradingView

Key Price Levels

TP1 Target
$484.91
Breakout Level
$469.71
Entry
$470.46
Stop Loss
$462.48

Fundamentals

P/E Ratio
N/A
EPS (TTM)
N/A
Dividend Yield
0%
52-Wk High
N/A
52-Wk Low
N/A
Beta
N/A

Deep Dive Analysis — Claude Sonnet

TRADE BRIEF — HCA Healthcare (HCA)

Generated by AlertEdge.io

SETUP

HCA is printing a breakout above $469.71 with price holding above the level on above-average volume at 1.67x. The bar structure shows a tight low equal to the open, suggesting buyers stepped in immediately at the session open with no early weakness. Price is now pressing toward the first target zone at $484.91. The structure is clean but the signal quality score of 50/100 flags this as a mid-range setup, meaning the move may already have some extension baked in. Risk is well-defined at $462.48, giving a workable 1:1.81 reward-to-risk ratio.

CATALYSTS

HCA operates as one of the largest for-profit hospital networks in the U.S. Healthcare tends to attract defensive capital in risk-off macro environments, which could provide a tailwind if broader market uncertainty persists. Hospital utilization trends have remained relatively stable post-pandemic. No specific near-term catalyst is confirmed here — earnings date and sector-specific news are unavailable, which is a notable gap. Traders should verify the next earnings date before sizing up, as HCA typically moves sharply on quarterly reports.

RISKS

The 50/100 signal quality score is the primary concern. This is not an early-in-move setup, and a chase entry risks getting caught in a fade if broader market sentiment shifts. Fundamentals data is entirely missing, which limits the ability to assess valuation risk or EPS momentum. No 52-week high is available, so it is unclear if this breakout is attacking fresh all-time highs or grinding into overhead supply. Healthcare faces regulatory headline risk at any time, particularly around reimbursement rates and Medicare policy. A close back below $469.71 would negate the setup.

CONVICTION: Medium — The price action and volume confirm a legitimate breakout structure, but the average signal quality score, absent fundamentals, and lack of a confirmed catalyst prevent a high-conviction rating.

Entry: $470.46

Stop: $462.48

TP1: $484.91

TP2: $494.54

R/R: 1:1.81

Verify earnings date before entry. Confirm no overhead resistance exists on a longer-term chart before adding to position at TP1.